Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Parallel-group, Open-label, Multicenter Study to Evaluate the Effects of Tocilizumab on Vaccination in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate

NCT01163747 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT01163747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01163747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Parallel-group, Open-label, Multicenter Study to Evaluate the Effects of Tocilizumab on Vaccination in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate
Lead sponsor
Genentech, Inc.
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2010
Completion date
June 30, 2012
Enrollment
91 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis